Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jan 15;97(2):331–338. doi: 10.1172/JCI118420

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

I A Heijnen 1, M J van Vugt 1, N A Fanger 1, R F Graziano 1, T P de Wit 1, F M Hofhuis 1, P M Guyre 1, P J Capel 1, J S Verbeek 1, J G van de Winkel 1
PMCID: PMC507022  PMID: 8567952

Abstract

Besides their phagocytic effector functions, myeloid cells have an essential role as accessory cells in the induction of optimal humoral immune responses by presenting captured antigens and activating lymphocytes. Antigen presentation by human monocytes was recently found to be enhanced in vitro through the high-affinity Fc receptor for IgG (Fc gamma RI; CD64), which is exclusively present on myeloid cells. To evaluate a comparable role of Fc gamma RI in antigen presentation in vivo, we generated human Fc gamma RI transgenic mice. Under control of its endogenous promoter, human Fc gamma RI was selectively expressed on murine myeloid cells at physiological expression levels. As in humans, expression was properly regulated by the cytokines IFN-gamma, G-CSF, IL-4, and IL-10, and was up-regulated during inflammation. The human receptor expressed by murine macrophages bound monomeric human IgG and mediated particle phagocytosis and IgG complex internalization. To evaluate whether specific targeting of antigens to Fc gamma RI can induce enhanced antibody responses, mice were immunized with an anti-human Fc gamma RI antibody containing antigenic determinants. Transgenic mice produced antigen-specific antibody responses with high IgG1 titers and substantial IgG2a and IgG2b responses. These data demonstrate that human Fc gamma RI on myeloid cells is highly active in mediating enhanced antigen presentation in vivo, and show that anti-Fc gamma RI mAbs are promising vaccine adjuvants.

Full Text

The Full Text of this article is available as a PDF (335.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. M., Seed B. Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science. 1989 Jan 20;243(4889):378–381. doi: 10.1126/science.2911749. [DOI] [PubMed] [Google Scholar]
  2. Anderson C. L., Shen L., Eicher D. M., Wewers M. D., Gill J. K. Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes. J Exp Med. 1990 Apr 1;171(4):1333–1345. doi: 10.1084/jem.171.4.1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dombrowicz D., Flamand V., Brigman K. K., Koller B. H., Kinet J. P. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene. Cell. 1993 Dec 3;75(5):969–976. doi: 10.1016/0092-8674(93)90540-7. [DOI] [PubMed] [Google Scholar]
  4. Gosselin E. J., Wardwell K., Gosselin D. R., Alter N., Fisher J. L., Guyre P. M. Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J Immunol. 1992 Dec 1;149(11):3477–3481. [PubMed] [Google Scholar]
  5. Graziano R. F., Tempest P. R., White P., Keler T., Deo Y., Ghebremariam H., Coleman K., Pfefferkorn L. C., Fanger M. W., Guyre P. M. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody. J Immunol. 1995 Nov 15;155(10):4996–5002. [PubMed] [Google Scholar]
  6. Grisolano J. L., Sclar G. M., Ley T. J. Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8989–8993. doi: 10.1073/pnas.91.19.8989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guyre P. M., Graziano R. F., Vance B. A., Morganelli P. M., Fanger M. W. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function. J Immunol. 1989 Sep 1;143(5):1650–1655. [PubMed] [Google Scholar]
  8. Kenney J. S., Hughes B. W., Masada M. P., Allison A. C. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Immunol Methods. 1989 Jul 26;121(2):157–166. doi: 10.1016/0022-1759(89)90156-7. [DOI] [PubMed] [Google Scholar]
  9. Kerst J. M., van de Winkel J. G., Evans A. H., de Haas M., Slaper-Cortenbach I. C., de Wit T. P., von dem Borne A. E., van der Schoot C. E., van Oers R. H. Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood. 1993 Mar 15;81(6):1457–1464. [PubMed] [Google Scholar]
  10. Larner A. C., David M., Feldman G. M., Igarashi K., Hackett R. H., Webb D. S., Sweitzer S. M., Petricoin E. F., 3rd, Finbloom D. S. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science. 1993 Sep 24;261(5129):1730–1733. doi: 10.1126/science.8378773. [DOI] [PubMed] [Google Scholar]
  11. Olweus J., Lund-Johansen F., Terstappen L. W. CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells. Blood. 1995 May 1;85(9):2402–2413. [PubMed] [Google Scholar]
  12. Osman N., Kozak C. A., McKenzie I. F., Hogarth P. M. Structure and mapping of the gene encoding mouse high affinity Fc gamma RI and chromosomal location of the human Fc gamma RI gene. J Immunol. 1992 Mar 1;148(5):1570–1575. [PubMed] [Google Scholar]
  13. Pahl H. L., Rosmarin A. G., Tenen D. G. Characterization of the myeloid-specific CD11b promoter. Blood. 1992 Feb 15;79(4):865–870. [PubMed] [Google Scholar]
  14. Pearse R. N., Feinman R., Ravetch J. V. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by gamma-interferon is mediated through common DNA response elements. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11305–11309. doi: 10.1073/pnas.88.24.11305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Perez C., Wietzerbin J., Benech P. D. Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism. Mol Cell Biol. 1993 Apr;13(4):2182–2192. doi: 10.1128/mcb.13.4.2182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pfefferkorn L. C., Fanger M. W. Transient activation of the NADPH oxidase through Fc gamma RI. Oxidase deactivation precedes internalization of cross-linked receptors. J Immunol. 1989 Oct 15;143(8):2640–2649. [PubMed] [Google Scholar]
  17. Ra C., Jouvin M. H., Blank U., Kinet J. P. A macrophage Fc gamma receptor and the mast cell receptor for IgE share an identical subunit. Nature. 1989 Oct 26;341(6244):752–754. doi: 10.1038/341752a0. [DOI] [PubMed] [Google Scholar]
  18. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 1988 Mar 24;332(6162):323–327. doi: 10.1038/332323a0. [DOI] [PubMed] [Google Scholar]
  19. Rodewald H. R., Moingeon P., Lucich J. L., Dosiou C., Lopez P., Reinherz E. L. A population of early fetal thymocytes expressing Fc gamma RII/III contains precursors of T lymphocytes and natural killer cells. Cell. 1992 Apr 3;69(1):139–150. doi: 10.1016/0092-8674(92)90125-v. [DOI] [PubMed] [Google Scholar]
  20. Sadowski H. B., Shuai K., Darnell J. E., Jr, Gilman M. Z. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science. 1993 Sep 24;261(5129):1739–1744. doi: 10.1126/science.8397445. [DOI] [PubMed] [Google Scholar]
  21. Sandor M., Galon J., Takacs L., Tatsumi Y., Mueller A. L., Sautes C., Lynch R. G. An alternative Fc gamma-receptor ligand: potential role in T-cell development. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12857–12861. doi: 10.1073/pnas.91.26.12857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Simms H. H., Frank M. M., Quinn T. C., Holland S., Gaither T. A. Studies on phagocytosis in patients with acute bacterial infections. J Clin Invest. 1989 Jan;83(1):252–260. doi: 10.1172/JCI113867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Skalnik D. G., Dorfman D. M., Perkins A. S., Jenkins N. A., Copeland N. G., Orkin S. H. Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8505–8509. doi: 10.1073/pnas.88.19.8505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Skalnik D. G., Strauss E. C., Orkin S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J Biol Chem. 1991 Sep 5;266(25):16736–16744. [PubMed] [Google Scholar]
  25. Takai T., Li M., Sylvestre D., Clynes R., Ravetch J. V. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell. 1994 Feb 11;76(3):519–529. doi: 10.1016/0092-8674(94)90115-5. [DOI] [PubMed] [Google Scholar]
  26. Taketo M., Schroeder A. C., Mobraaten L. E., Gunning K. B., Hanten G., Fox R. R., Roderick T. H., Stewart C. L., Lilly F., Hansen C. T. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2065–2069. doi: 10.1073/pnas.88.6.2065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tax W. J., van de Winkel J. G. Human Fc gamma receptor II: a standby receptor activated by proteolysis? Immunol Today. 1990 Sep;11(9):308–310. doi: 10.1016/0167-5699(90)90125-s. [DOI] [PubMed] [Google Scholar]
  28. Valerius T., Repp R., de Wit T. P., Berthold S., Platzer E., Kalden J. R., Gramatzki M., van de Winkel J. G. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood. 1993 Aug 1;82(3):931–939. [PubMed] [Google Scholar]
  29. Van Den Herik-Oudijk I. E., Westerdaal N. A., Henriquez N. V., Capel P. J., Van De Winkel J. G. Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes. J Immunol. 1994 Jan 15;152(2):574–585. [PubMed] [Google Scholar]
  30. Wallace P. K., Howell A. L., Fanger M. W. Role of Fc gamma receptors in cancer and infectious disease. J Leukoc Biol. 1994 Jun;55(6):816–826. doi: 10.1002/jlb.55.6.816. [DOI] [PubMed] [Google Scholar]
  31. Warren H. S., Vogel F. R., Chedid L. A. Current status of immunological adjuvants. Annu Rev Immunol. 1986;4:369–388. doi: 10.1146/annurev.iy.04.040186.002101. [DOI] [PubMed] [Google Scholar]
  32. de Waal Malefyt R., Figdor C. G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J. E. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol. 1993 Dec 1;151(11):6370–6381. [PubMed] [Google Scholar]
  33. te Velde A. A., Huijbens R. J., de Vries J. E., Figdor C. G. IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes. J Immunol. 1990 Apr 15;144(8):3046–3051. [PubMed] [Google Scholar]
  34. te Velde A. A., de Waal Malefijt R., Huijbens R. J., de Vries J. E., Figdor C. G. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol. 1992 Dec 15;149(12):4048–4052. [PubMed] [Google Scholar]
  35. van de Winkel J. G., Anderson C. L. Biology of human immunoglobulin G Fc receptors. J Leukoc Biol. 1991 May;49(5):511–524. doi: 10.1002/jlb.49.5.511. [DOI] [PubMed] [Google Scholar]
  36. van de Winkel J. G., Capel P. J. Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunol Today. 1993 May;14(5):215–221. doi: 10.1016/0167-5699(93)90166-I. [DOI] [PubMed] [Google Scholar]
  37. van de Winkel J. G., Ernst L. K., Anderson C. L., Chiu I. M. Gene organization of the human high affinity receptor for IgG, Fc gamma RI (CD64). Characterization and evidence for a second gene. J Biol Chem. 1991 Jul 15;266(20):13449–13455. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES